Leonard G. Frisbie

Leonard G. Frisbie

Auto-generated profile, based on publicly available information

Leonard G. Frisbie

Department of Integrative Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
HAHuda Issa Atiya
Huda Issa Atiya
GGGrace Gorecki
Grace Gorecki
GGGeyon L. Garcia
Geyon L. Garcia
LFLeonard G. Frisbie
Leonard G. Frisbie
RBRoja Baruwal
Roja Baruwal
LCLan Rinda Coffman
Lan Rinda Coffman
The ability of cancer cells to detach from the primary site and metastasize is the main cause of cancer- related death among all cancer types. Epithelial-to-mesenchymal transition (EMT) is the first event of the metastatic cascade, resulting in the loss of cell–cell adhesion and the acquisition of motile and stem-like phenotypes. A critical modulator of EMT in cancer cells is the stromal tumor microenvironment (TME), which can promote the acquisition of a mesenchymal phenotype through direct interaction with cancer cells or changes to the broader microenvironment. In this review, we will explore the role of stromal cells in modulating cancer cell EMT, with particular emphasis on the function of mesenchymal stromal/stem cells (MSCs) through the activation of EMT-inducing pathways, extra cellular matrix (ECM) remodeling, immune cell alteration, and metabolic rewiring.